Market Momentum Report: Astera Labs Inc (ALAB)’s Negative Close at 230.11

Kevin Freeman

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The price of Astera Labs Inc (NASDAQ: ALAB) closed at $230.11 in the last session, down -3.03% from day before closing price of $237.3. In other words, the price has decreased by -$3.03 from its previous closing price. On the day, 6.13 million shares were traded. ALAB stock price reached its highest trading level at $236.49 during the session, while it also had its lowest trading level at $219.25.

Ratios:

We take a closer look at ALAB’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 35.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 181.82. For the most recent quarter (mrq), Quick Ratio is recorded 10.55 and its Current Ratio is at 11.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 02 ’25 when ALBA MANUEL sold 183,000 shares for $173.27 per share. The transaction valued at 31,707,713 led to the insider holds 385,863 shares of the business.

Mazzara Philip sold 10,000 shares of ALAB for $1,886,956 on Aug 28 ’25. The General Counsel and Secretary now owns 161,573 shares after completing the transaction at $188.70 per share. On Sep 02 ’25, another insider, CASA ALAMEDA 2007, LLC, who serves as the Director of the company, bought 33,000 shares for $182.20 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 39443804160 and an Enterprise Value of 37215907840. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 403.49, and their Forward P/E ratio for the next fiscal year is 111.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 63.16 while its Price-to-Book (P/B) ratio in mrq is 33.68. Its current Enterprise Value per Revenue stands at 61.458 whereas that against EBITDA is 797.82.

Stock Price History:

The Beta on a monthly basis for ALAB is 1.70, which has changed by 3.4166985 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is 32.36%, while the 200-Day Moving Average is calculated to be 105.33%.

Shares Statistics:

According to the various share statistics, ALAB traded on average about 5.92M shares per day over the past 3-months and 6862270 shares per day over the past 10 days. A total of 166.21M shares are outstanding, with a floating share count of 127.24M. Insiders hold about 23.45% of the company’s shares, while institutions hold 61.18% stake in the company. Shares short for ALAB as of 1756425600 were 9206501 with a Short Ratio of 1.55, compared to 1753920000 on 9280319. Therefore, it implies a Short% of Shares Outstanding of 9206501 and a Short% of Float of 7.53.

Earnings Estimates

Current recommendations for the stock of the company come from 13.0 analysts. The consensus estimate for the next quarter is $0.42, with high estimates of $0.46 and low estimates of $0.39.

Analysts are recommending an EPS of between $1.62 and $1.55 for the fiscal current year, implying an average EPS of $1.58. EPS for the following year is $2.05, with 15.0 analysts recommending between $2.67 and $1.8.

Revenue Estimates

According to 12 analysts, the current quarter’s revenue is expected to be $206.38M. It ranges from a high estimate of $208.1M to a low estimate of $201.52M. As of the current estimate, Astera Labs Inc’s year-ago sales were $113.09MFor the next quarter, 12 analysts are estimating revenue of $216.48M. There is a high estimate of $222.3M for the next quarter, whereas the lowest estimate is $209.58M.

A total of 15 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $805M, while the lowest revenue estimate was $762.47M, resulting in an average revenue estimate of $776.71M. In the same quarter a year ago, actual revenue was $396.29MBased on 14 analysts’ estimates, the company’s revenue will be $1.02B in the next fiscal year. The high estimate is $1.15B and the low estimate is $972.5M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.